Skip to main content

Table 3 Risk assessment of clinical parameters for advanced fibrosis

From: Validation of the BARD scoring system in Polish patients with nonalcoholic fatty liver disease (NAFLD)

Variable

Fibrosis 0-2 (n = 88)

Fibrosis 3-4 (n = 15)

p

OR

95% CI

Age ≥ 50 years

39 (44.3%)

11 (73.3%)

0.038

3.455

1.021-11.694

BMI ≥ 28

58 (65.9%)

10 (66.7%)

0.954

1.034

0.324-3.302

DMt2

14 (15.9%)

5 (33.3%)

0.109

2.643

0.783-8.916

HOMA (<1.8)

32(46.4%)

7(70%)

0.193

2.698

0.644-11.306

AST/ALT ≥ 0,8

17 (19.3%)

13 (86.7%)

p < 0.001

27.147

5.592-131.974

Back to article page

BMC Gastroenterology

ISSN: 1471-230X

Contact us